Article info

Download PDFPDF
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
  1. Dr S G Priglinger, Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Mathildenstr 8, 80336 Munich, Germany; siegfried.priglinger{at}med.uni-muenchen.de
View Full Text

Citation

Kreutzer TC, Alge CS, Wolf AH, et al
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

Publication history

  • Accepted November 27, 2007
  • First published January 22, 2008.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.